Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;229(Pt A):109107.
doi: 10.1016/j.drugalcdep.2021.109107. Epub 2021 Sep 27.

Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020

Affiliations

Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020

Jonathan Cantor et al. Drug Alcohol Depend. .

Abstract

Background: Understanding whether individuals have geographic accessibility to a substance use disorder treatment facility and a treatment facility that offers medication treatment for opioid use disorder (MOUD) can inform efforts to address the ongoing opioid crisis.

Methods: We used data from the National Directory of Drug and Alcohol Abuse Treatment Programs. First, we calculate the national share of treatment facilities that offer one type of MOUD or all forms of MOUD using a novel dataset of providers. Second, we quantify the share of counties with a treatment facility offering at least one type of MOUD. Finally, we calculate the share of the national population residing within a 10-mile radius of a treatment facility.

Results: The share of counties with a treatment facility offering a MOUD as a form of treatment rose from 30% to 45% from 2014 to 2020 while the share of counties with facilities offering all three forms of MOUD increased from 4% to 9%. Over 83% of the population lives within 10 miles of a facility offering MOUD treatment, and 42% of the population have a treatment facility that offers all three forms of MOUD within a 10-mile radius. Much of the difference between the county- and population-based measures is explained by more population dense areas having higher rates of facilities providing MOUD.

Conclusions: While the share of facilities within a county offering a MOUD is relatively small, the share of the population within 10 miles of such a facility is higher.

Keywords: Access to care; Medications for opioid use disorder.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The study sponsor had no role in study design; collection, analysis and interpretation of data; writing the report; and the decision to submit the report for publication.

Figures

Figure A1:
Figure A1:
Percent of population by Census Block Group with a Treatment Facility within 10-miles Notes: This map studies access to facilities offering all three types of MOUD. The shaded areas in the map above represent counties and areas that do not have facilities in or near them that offer all three forms of MOUD. The gray areas are areas where there are no facilities present within a given county and there are no facilities present within a 10-mile radius of a Census Block Group. The areas in blue have a facility offering all three forms of MOUD within a 10-mile radius but not within its county. The areas in green have facilities offering all forms of MOUD within the same county as well as facilities within a 10-mile radius.
Figure A2:
Figure A2:
Percent of population by Census Block Group with a Treatment Facility within 25-miles Notes: Each bar represents the percentage of the population within 25 miles of 0, 1–4, or 5+ treatment facilities meeting criteria listed at base.
Figure A3:
Figure A3:
Map of Differences in County and Population Geographic Access to Treatment Centers Offering All Three Forms of MOUD in 2020 Note: This map studies access to facilities offering all three types of MOUD. The shaded areas in the map above represent counties and areas that do not have facilities in or near them that offer all three forms of MOUD. The gray areas are areas where there are no facilities present within a given county and there are no facilities present within a 25-mile radius of a Census Block Group. The areas in blue have a facility offering all three forms of MOUD within a 25-mile radius but not within its county. The areas in green have facilities offering all forms of MOUD within the same county as well as facilities within a 25-mile radius.
Figure A4:
Figure A4:
Percent of population by Census Block Group with a Treatment Facility within 50-miles Notes: Each bar represents the percentage of the population within 50 miles of 0, 1–4, or 5+ treatment facilities meeting criteria listed at base.
Figure A5:
Figure A5:
Map of Differences in County and Population Geographic Access to Treatment Centers Offering All Three Forms of MOUD in 2020 Note: This map studies access to facilities offering all three types of MOUD. The shaded areas in the map above represent counties and areas that do not have facilities in or near them that offer all three forms of MOUD. The gray areas are areas where there are no facilities present within a given county and there are no facilities present within a 50-mile radius of a Census Block Group. The areas in blue have a facility offering all three forms of MOUD within a 50-mile radius but not within its county. The areas in green have facilities offering all forms of MOUD within the same county as well as facilities within a 50-mile radius.
Figure 1
Figure 1
1a: Share of facilities offering types of MOUD (2014–2020) 1b: Share of counties offering types of MOUD (2014–2020) Notes: MOUD includes buprenorphine, methadone and naltrexone. In Panel A, the yellow line indicates the share of facilities that report offering at least one form of MOUD in each year. The grey line indicates the share of facilities that report offering two or more forms of MOUD treatment. The orange line indicates the share of facilities that offer all three forms of MOUD over time. In Panel B, each line corresponds to the share of counties with a facility providing access to MOUD treatment.
Figure 1
Figure 1
1a: Share of facilities offering types of MOUD (2014–2020) 1b: Share of counties offering types of MOUD (2014–2020) Notes: MOUD includes buprenorphine, methadone and naltrexone. In Panel A, the yellow line indicates the share of facilities that report offering at least one form of MOUD in each year. The grey line indicates the share of facilities that report offering two or more forms of MOUD treatment. The orange line indicates the share of facilities that offer all three forms of MOUD over time. In Panel B, each line corresponds to the share of counties with a facility providing access to MOUD treatment.
Figure 2:
Figure 2:
County-Level Measures for Facilities and MOUD Notes: Each bar represents the percentage of counties with 0, 1–4, or 5+ treatment facilities meeting criteria listed at base.
Figure 3:
Figure 3:
Percent of population by Census Block Group with a Treatment Facility within 10-miles Notes: Each bar represents the percentage of the population within 10 miles of 0, 1–4, or 5+ treatment facilities meeting criteria listed at base.
Figure 4:
Figure 4:
Share of the country that does not have a facility in the county but within 10-, 25-, and 50-miles in 2020 Notes: Denominator is the total population of counties that do not have a treatment facility in the county. The numerator is the total population that does not have a facility in their county but does have a facility within 10-, 25- and 50-miles from the centroid of their census tract.

References

    1. Abraham AJ, Andrews CM, Yingling ME, Shannon J, 2018. Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees. Health Services Research 53, 389–404. 10.1111/1475-6773.12686 - DOI - PMC - PubMed
    1. Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2021. [WWW Document], n.d. URL https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm (accessed 3.3.21).
    1. Alexander GC, Stoller KB, Haffajee RL, Saloner B, 2020. An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Ann Intern Med. 10.7326/M20-1141 - DOI - PMC - PubMed
    1. Amiri S, McDonell MG, Denney JT, Buchwald D, Amram O, 2021. Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis. Value Health 24, 188–195. 10.1016/j.jval.2020.08.2098 - DOI - PubMed
    1. Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML, 2020. Therapies Offered at Residential Addiction Treatment Programs in the United States. JAMA 324, 804. 10.1001/jama.2020.8969 - DOI - PMC - PubMed

Publication types